Company / Working Capital
Corbus Pharmaceuticals Holdings, Inc. Working Capital History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$47.5M
FY2022
5-year range
$3.3M / $83.2M
FY2018-FY2022
Trend
-42.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 8 years, ranging from $3M in FY2019 to $83M in FY2021.
Based on SEC 10-K filings.
$48M in FY2022 with a 5-year CAGR of -3.7%.
Declined from $60M to $48M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +144.1%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.7%, indicating a declining trend.
- In FY2022, working capital decreased 42.9% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $47.5M | -42.9% |
| FY2021 | $83.2M | +38.3% |
| FY2020 | $60.2M | +1742.0% |
| FY2019 | $3.3M | -87.5% |
| FY2018 | $26.2M | -54.4% |
| FY2017 | $57.3M | +573.8% |
| FY2016 | $8.5M | -6.4% |
| FY2015 | $9.1M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026